Do you want to read an article? Please log in or register.
Adjudicated Cardiovascular Events in Patients With COVID-19: Association With Vaccination Status and Changes over Time
Cardiovascular Risk and Diseases
RECOMMENDED
Related content
ESC 2025
Cardiovascular Risk and Diseases
Preventive potential of vaccination against herpes zoster on cardiovascular event risk
Cardiovascular Risk and DiseasesTherapy and Intervention
Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial
Lancet
Choi KH, Park YH, Lee JY, Jeong JO, Kim CJ, Yun KH, Lee HC, Chang K, Park MW, Bae JW, Doh JH, Cho BR, Kim HY, Kim W, Kim U, Rha SW, Hong YJ, Lee HJ, Ahn SG, Kim DI, Cho JH, Her SH, Jeon DS, Han SH, Lee JB, Lee CW, Kang D, Lee JM, Park TK, Yang JH, Lee SY, Choi SH, Gwon HC, Song YB, Hahn JY, SMART-CHOICE 3 investigators
doi: 10.1016/S0140-6736(25)00449-0
Heart, Artery and Coronary Diseases
Association between SSRI use and cardiovascular outcomes in patients with coronary artery disease and generalized anxiety disorder: A real-world cohort study
Atherosclerosis
Wu JY, Chang HY, Kao CL, Hung KC, Yu T, Lin YM
doi: 10.1016/j.atherosclerosis.2025.120390
Cardiovascular Risk and Diseases
Association between inflammatory bowel disease, current therapies, and cardiovascular events: a review and meta-analysis of data from 2.2 million individuals
J Crohns Colitis
Thomas DR, Huangfu G, Yeaman F, Sukudom S, Lan NSR, Dwivedi G, Thin L
doi: 10.1093/ecco-jcc/jjaf078
Cardiovascular Risk and Diseases
Expanded Field OCTA Biomarkers Associated with Future Cardiovascular Disease and Mortality in Patients with Diabetic Retinopathy
Retina
Lu ES, Cui Y, Phu KK, Ding X, Nodecker KN, Le R, Zhu Y, Garg I, Baldwin G, Rodriguez J, Finn MJ, Razavi P, Laíns I, Wu DM, Husain D, Kim LA, Patel NA, Vavvas DG, Miller JB
doi: 10.1097/IAE.0000000000004695
Heart Failure
Effects of dapagliflozin on blood volume status and vascular outcomes in clinically stabilized heart failure patients after an acute decompensated heart failure event (DAPA-VOLVO study): Protocol of a double-blind randomized controlled clinical trial
PLoS One
Bitos K, Laptseva N, Haider T, Rossi VA, Nägele MP, Barthelmes J, Ruschitzka F, Sudano I, Flammer AJ
doi: 10.1371/journal.pone.0325668
Heart Failure
Prognostic impact of frailty at admission and in-hospital changes of frailty status in elderly patients with acute heart failure
Eur J Heart Fail
Kaufmann CC, Ahmed A, Harbich PF, Auer L, Propst L, Weltler P, Burger AL, Zweiker D, Geppert A, Huber K, Jäger B
doi: 10.1002/ejhf.3779
Cardiovascular Risk and Diseases
Cardiovascular risk assessment tools are insufficient for patients with metabolic dysfunction associated steatotic liver disease
Am J Gastroenterol
Barritt AS 4th, Tapper EB, Newsome PN, Gazis D, Morris H, Mospan AR, Perez AD, Kim Y, Neuschwander-Tetri BA, Loomba R, Sanyal A, TARGET-NASH Investigators
doi: 10.14309/ajg.0000000000003595
COMMENTED
Cardiovascular Risk and Diseases
Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol
Patsoukaki V, Lind L, Lampa E, Radhi S, Eeg-Olofsson K, Eliasson B, Eriksson JW
doi: 10.1016/S2213-8587(25)00165-2